S&P 500   3,453.49 (+0.52%)
DOW   28,363.66 (+0.54%)
QQQ   284.17 (+-0.01%)
AAPL   115.89 (-0.84%)
MSFT   214.76 (-0.02%)
FB   278.42 (-0.11%)
GOOGL   1,609.98 (+1.51%)
AMZN   3,178.00 (-0.22%)
TSLA   426.46 (+0.90%)
NVDA   533.80 (-1.33%)
BABA   306.36 (-0.52%)
CGC   20.30 (+4.16%)
GE   7.75 (+5.87%)
MU   53.95 (+1.20%)
AMD   81.05 (+2.34%)
T   28.24 (+5.69%)
F   8.22 (+4.71%)
ACB   4.85 (+0.00%)
GILD   62.95 (+4.55%)
NFLX   485.23 (-0.78%)
BA   169.01 (+3.14%)
NIO   27.41 (-1.62%)
BAC   24.90 (+3.53%)
S&P 500   3,453.49 (+0.52%)
DOW   28,363.66 (+0.54%)
QQQ   284.17 (+-0.01%)
AAPL   115.89 (-0.84%)
MSFT   214.76 (-0.02%)
FB   278.42 (-0.11%)
GOOGL   1,609.98 (+1.51%)
AMZN   3,178.00 (-0.22%)
TSLA   426.46 (+0.90%)
NVDA   533.80 (-1.33%)
BABA   306.36 (-0.52%)
CGC   20.30 (+4.16%)
GE   7.75 (+5.87%)
MU   53.95 (+1.20%)
AMD   81.05 (+2.34%)
T   28.24 (+5.69%)
F   8.22 (+4.71%)
ACB   4.85 (+0.00%)
GILD   62.95 (+4.55%)
NFLX   485.23 (-0.78%)
BA   169.01 (+3.14%)
NIO   27.41 (-1.62%)
BAC   24.90 (+3.53%)
S&P 500   3,453.49 (+0.52%)
DOW   28,363.66 (+0.54%)
QQQ   284.17 (+-0.01%)
AAPL   115.89 (-0.84%)
MSFT   214.76 (-0.02%)
FB   278.42 (-0.11%)
GOOGL   1,609.98 (+1.51%)
AMZN   3,178.00 (-0.22%)
TSLA   426.46 (+0.90%)
NVDA   533.80 (-1.33%)
BABA   306.36 (-0.52%)
CGC   20.30 (+4.16%)
GE   7.75 (+5.87%)
MU   53.95 (+1.20%)
AMD   81.05 (+2.34%)
T   28.24 (+5.69%)
F   8.22 (+4.71%)
ACB   4.85 (+0.00%)
GILD   62.95 (+4.55%)
NFLX   485.23 (-0.78%)
BA   169.01 (+3.14%)
NIO   27.41 (-1.62%)
BAC   24.90 (+3.53%)
S&P 500   3,453.49 (+0.52%)
DOW   28,363.66 (+0.54%)
QQQ   284.17 (+-0.01%)
AAPL   115.89 (-0.84%)
MSFT   214.76 (-0.02%)
FB   278.42 (-0.11%)
GOOGL   1,609.98 (+1.51%)
AMZN   3,178.00 (-0.22%)
TSLA   426.46 (+0.90%)
NVDA   533.80 (-1.33%)
BABA   306.36 (-0.52%)
CGC   20.30 (+4.16%)
GE   7.75 (+5.87%)
MU   53.95 (+1.20%)
AMD   81.05 (+2.34%)
T   28.24 (+5.69%)
F   8.22 (+4.71%)
ACB   4.85 (+0.00%)
GILD   62.95 (+4.55%)
NFLX   485.23 (-0.78%)
BA   169.01 (+3.14%)
NIO   27.41 (-1.62%)
BAC   24.90 (+3.53%)
Log in
NASDAQ:LMAT

LeMaitre Vascular Stock Forecast, Price & News

$32.50
+1.06 (+3.37 %)
(As of 10/22/2020 03:59 PM ET)
Add
Compare
Today's Range
$31.84
Now: $32.50
$32.57
50-Day Range
$30.84
MA: $32.36
$33.98
52-Week Range
$18.76
Now: $32.50
$38.64
Volume871 shs
Average Volume133,060 shs
Market Capitalization$657.38 million
P/E Ratio40.12
Dividend Yield1.19%
Beta1.33
LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. The company offers angioscope, a fiber optic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude the blood flow; perfusion catheters to temporarily perfuse the blood and other fluids into the vasculature; and thrombectomy catheters, which features a silicone balloon for removing thrombi in the venous system. It also provides carotid shunts that temporarily shunt the blood to the brain during the removal of plaque from the carotid artery in a carotid endarterectomy surgery; powered phlebectomy devices to remove varicose veins; and radiopaque tape, a medical-grade tape applied to the skin that enables interventionists to cross-refer between the inside and the outside of a patient's body, and allows them to locate tributaries or lesions beneath the skin. In addition, the company offers remote endarterectomy devices to remove plaque from arteries in the leg; valvulotomes, which cut valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and vascular grafts to bypass or replace diseased arteries. Further, it provides vascular patches, which are used for closure of vessels after surgical intervention, as well as endarterectomy and other vascular reconstruction; vessel closure systems to attach vessels to one another with titanium clips instead of sutures; and surgical glue. The company markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was founded in 1983 and is headquartered in Burlington, Massachusetts.
Read More
LeMaitre Vascular logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.3Community Rank: 2.9Dividend Strength: 1.7Insider Behavior: 1.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.62 out of 5 stars

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:LMAT
CUSIPN/A
Phone781-221-2266
Employees454

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$117.23 million
Cash Flow$1.17 per share
Book Value$7.41 per share

Profitability

Net Income$17.93 million

Miscellaneous

Market Cap$657.38 million
Next Earnings Date10/29/2020 (Confirmed)
OptionableOptionable
$32.50
+1.06 (+3.37 %)
(As of 10/22/2020 03:59 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive LMAT News and Ratings via Email

Sign-up to receive the latest news and ratings for LMAT and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











LeMaitre Vascular (NASDAQ:LMAT) Frequently Asked Questions

How has LeMaitre Vascular's stock price been impacted by Coronavirus (COVID-19)?

LeMaitre Vascular's stock was trading at $26.10 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, LMAT shares have increased by 24.5% and is now trading at $32.50.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of LeMaitre Vascular?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for LeMaitre Vascular in the last year. There are currently 3 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for LeMaitre Vascular
.

When is LeMaitre Vascular's next earnings date?

LeMaitre Vascular is scheduled to release its next quarterly earnings announcement on Thursday, October 29th 2020.
View our earnings forecast for LeMaitre Vascular
.

How can I listen to LeMaitre Vascular's earnings call?

LeMaitre Vascular will be holding an earnings conference call on Thursday, October 29th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were LeMaitre Vascular's earnings last quarter?

LeMaitre Vascular, Inc. (NASDAQ:LMAT) posted its quarterly earnings data on Thursday, July, 23rd. The medical instruments supplier reported $0.17 earnings per share for the quarter, beating the Zacks' consensus estimate of $0.01 by $0.16. The medical instruments supplier earned $24.85 million during the quarter, compared to analyst estimates of $15.58 million. LeMaitre Vascular had a net margin of 14.36% and a return on equity of 11.13%.
View LeMaitre Vascular's earnings history
.

How often does LeMaitre Vascular pay dividends? What is the dividend yield for LeMaitre Vascular?

LeMaitre Vascular announced a quarterly dividend on Monday, July 27th. Investors of record on Thursday, August 27th will be given a dividend of $0.095 per share on Thursday, September 10th. This represents a $0.38 dividend on an annualized basis and a dividend yield of 1.17%. The ex-dividend date of this dividend is Wednesday, August 26th.
View LeMaitre Vascular's dividend history
.

What price target have analysts set for LMAT?

7 brokers have issued 12 month price targets for LeMaitre Vascular's shares. Their forecasts range from $28.00 to $40.00. On average, they anticipate LeMaitre Vascular's share price to reach $33.14 in the next twelve months. This suggests a possible upside of 2.0% from the stock's current price.
View analysts' price targets for LeMaitre Vascular
.

Who are some of LeMaitre Vascular's key competitors?

What other stocks do shareholders of LeMaitre Vascular own?

Based on aggregate information from My MarketBeat watchlists, some companies that other LeMaitre Vascular investors own include Canopy Growth (CGC), AbbVie (ABBV), Sociedad Química y Minera de Chile (SQM), Gilead Sciences (GILD), Aurora Cannabis (ACB), Aurora Cannabis (ACBFF), NVIDIA (NVDA), Adobe (ADBE), The Boeing (BA) and salesforce.com (CRM).

Who are LeMaitre Vascular's key executives?

LeMaitre Vascular's management team includes the following people:
  • Mr. George W. LeMaitre, Chairman & CEO (Age 55, Pay $678.25k)
  • Mr. David B. Roberts, Pres & Director (Age 56, Pay $498.87k)
  • Mr. Joseph P. Pellegrino Jr., CFO, Treasurer, Sec. & Director (Age 55, Pay $438.02k)
  • Mr. Trent G. Kamke, Sr. VP of Operations (Age 49, Pay $357.85k)
  • Dr. George D. LeMaitre, Founder and Chairman of Scientific Advisory Board (Age 86)

What is LeMaitre Vascular's stock symbol?

LeMaitre Vascular trades on the NASDAQ under the ticker symbol "LMAT."

Who are LeMaitre Vascular's major shareholders?

LeMaitre Vascular's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Summit Creek Advisors LLC (2.34%), Envestnet Asset Management Inc. (0.64%), State of Alaska Department of Revenue (0.08%), Louisiana State Employees Retirement System (0.04%) and Peak Financial Management Inc. (0.04%). Company insiders that own LeMaitre Vascular stock include David B Roberts, George W Lemaitre, Joseph P Pellegrino Jr, Lawrence J Jasinski, Michael H Thomas and Trent G Kamke.
View institutional ownership trends for LeMaitre Vascular
.

Which major investors are buying LeMaitre Vascular stock?

LMAT stock was purchased by a variety of institutional investors in the last quarter, including Summit Creek Advisors LLC, Envestnet Asset Management Inc., Louisiana State Employees Retirement System, Peak Financial Management Inc., and State of Alaska Department of Revenue.
View insider buying and selling activity for LeMaitre Vascular
.

How do I buy shares of LeMaitre Vascular?

Shares of LMAT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is LeMaitre Vascular's stock price today?

One share of LMAT stock can currently be purchased for approximately $32.50.

How big of a company is LeMaitre Vascular?

LeMaitre Vascular has a market capitalization of $657.38 million and generates $117.23 million in revenue each year. The medical instruments supplier earns $17.93 million in net income (profit) each year or $0.88 on an earnings per share basis. LeMaitre Vascular employs 454 workers across the globe.

What is LeMaitre Vascular's official website?

The official website for LeMaitre Vascular is www.lemaitre.com.

How can I contact LeMaitre Vascular?

LeMaitre Vascular's mailing address is 63 SECOND AVENUE, BURLINGTON MA, 01803. The medical instruments supplier can be reached via phone at 781-221-2266.

This page was last updated on 10/22/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.